The eTRANSAFE project on translational safety assessment through integrative knowledge management: achievements and perspectives
Visualitza/Obre
Cita com:
hdl:2117/341905
Tipus de documentArticle
Data publicació2021
EditorMDPI
Condicions d'accésAccés obert
Llevat que s'hi indiqui el contrari, els
continguts d'aquesta obra estan subjectes a la llicència de Creative Commons
:
Reconeixement 3.0 Espanya
Abstract
eTRANSAFE is a research project funded within the Innovative Medicines Initiative (IMI), which aims at developing integrated databases and computational tools (the eTRANSAFE ToxHub) that support the translational safety assessment of new drugs by using legacy data provided by the pharmaceutical companies that participate in the project. The project objectives include the development of databases containing preclinical and clinical data, computational systems for translational analysis including tools for data query, analysis and visualization, as well as computational models to explain and predict drug safety events.
CitacióPognan, F. [et al.]. The eTRANSAFE project on translational safety assessment through integrative knowledge management: achievements and perspectives. "Pharmaceuticals", 2021, vol. 14, núm. 3, 237.
ISSN1424-8247
Versió de l'editorhttps://www.mdpi.com/1424-8247/14/3/237#
Col·leccions
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
pharmaceuticals-14-00237-v2.pdf | 4,697Mb | Visualitza/Obre |